Recently Viewed

    JNapodano

    Jason Napodano, CFA Joined Dec 22, 2010

    Professional biotech analyst for the past 16 years. I work with biopharma companies to provide quality content and analysis for investors. No pump! I only post here, so please reply to me on Twitter.

    Followers

    1. Thumb-1341490798
      StrategyDesk
      Czupko Robert
      Robert Czupko - The best of stock and option setup
    2. Thumb-1425004400
      molehill
      mole hill
    3. Thumb-1453690621
      ironlake2
      Maryann Schulten
    4. Thumb-1462540915
      Halstadt1
      Richard Street
    5. Default_avatar_thumb
      Ela75
      Ela
    6. Thumb-1445045096
      DonB11
      Don B
      Just charts no guessing and a lil bit of HW. Out here tryna get that lion share daddy..
    7. Thumb-1432926426
      asnybull
      Andy Stein
    8. Thumb-1457377774
      Lucky621
      BobbyG
    9. Thumb-1380900287
      DebraSue
      Debra Rose
    10. Thumb-1453936961
      Trev4
      Trev4
      Where would Wall Street be without a herd mentality in a zero sum game?
    11. Thumb-1461350242
      nyctj7
      Spanky and the Gang
      Lil Rascals
    12. Default_avatar_thumb
    13. Thumb-1390921159
      Retro807
      Angelo
    14. Thumb-1448266451
      IMBECILE_wisdom
      Imbecilicious
      Long term and bottom fishing with particularly the latter producing some nice results, therefore..... don't underestimate IMBECILE ;-)
    15. Default_avatar_thumb
      citrati
      Charles McConnell
    16. Thumb-1438364551
      swagswag
      swagswag
    17. Thumb-1415103916
      blackwhalecapital
      Black Whale Capital
    18. Default_avatar_thumb
      sttns
      David Einhorn
    19. Thumb-1451833743
      Prospern
      Prospering
      40 year old Banker, Investor and Marquette U Alum. Entering a stock is a science. Exiting is a discipline. Staying humble keeps you in the game. Disclosure: In 2015 turned $114k into $1.12M in the four accounts that I manage.
    20. Thumb-1429598242
      jockinmikeg
      Michael
      Trade mainly small caps, microcaps, and ETFs